Recalls & Warnings December 08, 2020 FTC Sends Refund Checks to Consumers of Deceptive Joint Pain Supplement Synovia On December 1, 2020, the FTC announced it is mailing 13,221 checks totaling nearly $775,000 to consumers who bought Synovia, a supplement intended to treat joint pain and arthritis
Tesamorelin Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH)
Actual dosing, treatment length, and recommendations are determined by provider evaluation and individual patient needs
A Category 1 listing only means a compound can be legally prepared by 503A compounding pharmacies it does not make BPC-157 an FDA-approved drug
Options include: COX-2 inhibitors like celecoxib (Celebrex) Opioids Tramadol (Ultram) Surgery As mentioned, Highlander says surgery can be useful to release pressure on a nerve and may help to treat damage that occurs due to carpal tunnel syndrome and diabetic neuropathy
Three years ago, the FDA determined that certain peptides should not be compounded, citing significant safety concerns, including the risk of life-threatening allergic reactions